Lv1
20 积分 2022-02-24 加入
Immune checkpoint inhibitors in high-grade gastroenteropancreatic neuroendocrine neoplasms
6个月前
已完结
Immune checkpoint inhibitors in high-grade gastroenteropancreatic neuroendocrine neoplasms
7个月前
已完结
In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy
8个月前
已完结
皖公网安备34019202002308
